A phase Ia study of four dose levels of LX 2931 in healthy volunteers.
Phase of Trial: Phase I
Latest Information Update: 25 Oct 2008
At a glance
- Drugs LX 2931 (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Lexicon Pharmaceuticals
- 25 Oct 2008 Results presented at the American College of Rheumatology 2008 annual meeting.
- 25 Oct 2008 New trial record.